Drug Shortage Report for ZEJULA

Last updated on 2023-09-28 History
Report ID 200374
Drug Identification Number 02489783
Brand name ZEJULA
Common or Proper name niraparib capsules
Market Status MARKETED
Active Ingredient(s) NIRAPARIB
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 84
ATC code L01XX
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-07-31
Estimated end date
Actual end date 2023-09-25
Shortage status Resolved
Updated date 2023-09-28
Company comments No further supply of capsules available. Zejula can be ordered in the tablet format as of September 25, 2023. For any questions, contact GSK Customer Service at 1-800-387-7374 or cacsu@gsk.com.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-07-28 English Compare
v2 2023-07-28 French Compare
v3 2023-08-02 English Compare
v4 2023-08-02 French Compare
v5 2023-09-28 English Compare
v6 2023-09-28 French Compare

Showing 1 to 6 of 6